Pediatric Mineral and Bone Disorder of Chronic Kidney Disease and Cardiovascular Disease

Area of Science:

• Nephrology
• Cardiology
• Pediatrics

Background:

• Chronic kidney disease (CKD) is a prevalent condition associated with significant morbidity and mortality, primarily due to cardiovascular disease.
• Cardiovascular disease in CKD patients is linked to abnormal calcium and phosphorus metabolism, termed mineral and bone disorder (MBD) of CKD.
• MBD of CKD contributes to vascular calcification and long-term cardiovascular complications.

Purpose of the Study:

• To discuss the intricate relationship between cardiovascular and bone diseases in patients with CKD and end-stage kidney disease (ESKD).
• To highlight the specific challenges and concerns related to MBD of CKD management in pediatric populations, including linear growth and skeletal maturation.
• To emphasize the potential benefits of effective bone disease management on cardiovascular health in CKD patients.

Main Methods:

• Review of current literature on mineral and bone disorder of CKD.
• Analysis of the pathophysiology linking renal bone disease, mineral metabolism, and cardiovascular disease.
• Focus on pediatric-specific considerations in MBD of CKD management.

Main Results:

• Mineral and bone disorder of CKD is a key driver of cardiovascular disease in CKD patients.
• Effective management of bone disease may improve cardiovascular status.
• Pediatric patients face unique challenges in managing MBD of CKD.

Conclusions:

• Mineral and bone disorder of CKD is a critical factor influencing cardiovascular outcomes in both adult and pediatric populations.
• Addressing bone health is essential for mitigating cardiovascular risks in CKD.
• Pediatric nephrologists require tailored strategies for managing MBD of CKD to optimize growth and skeletal development alongside cardiovascular health.